Literature DB >> 31335575

The Use of a Venous Catheter as a Stent for Treatment of Acquired Punctal and Canalicular Stenosis.

Alessandro Meduri1, Leandro Inferrera1, Giuseppe Tumminello1, Rino Frisina2, Matteo Forlini3, Stephen Kaufman4, Pasquale Aragona1.   

Abstract

PURPOSE: The aim of this study was to describe a simple technique to insert a venous catheter as a stent for the treatment of acquired punctal and canalicular stenosis.
METHODS: We performed this technique using a central venous catheter as a stent for the treatment of acquired punctal and canalicular stenosis.
RESULTS: The results show the easy availability of the material used for the intervention, its easy execution, and the low costs of materials. The goal of this technique is to have a lacrimal dot dilated and canalicular duct easy to irrigate.
CONCLUSION: The use of a venous catheter as a stent for treatment of acquired punctal and canalicular stenosis seems to be simple, safe, repeatable, and noninvasive.

Entities:  

Mesh:

Year:  2019        PMID: 31335575     DOI: 10.1097/SCS.0000000000005743

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  Rectangular 3-snip punctoplasty versus punch punctoplasty with silicone intubation for acquired external punctal stenosis: a prospective randomized comparative study.

Authors:  Xin Cao; Zi-Zhong Hu; Ying Wu; Yu Song; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

2.  Repositioning of the Severe Prolapsed Silicone Tubes after Bicanalicular Nasal Intubation: A Novel Technique.

Authors:  Jinjing He; Jingwen Gong; Qingqing Zheng; Jin Jiang
Journal:  J Ophthalmol       Date:  2021-03-06       Impact factor: 1.909

3.  A Comparison of Transcanalicular, Endonasal, and External Dacryocystorhinostomy in Functional Epiphora: A Minimum Two-Year Follow-Up Study.

Authors:  Can Ozturker; Bayasgalan Purevdorj; Gamze Ozturk Karabulut; Gamal Seif; Korhan Fazil; Yasser Anwar Khan; Pelin Kaynak
Journal:  J Ophthalmol       Date:  2022-03-23       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.